Received: 26 June 2020
Accepted: 13 October 2020
First Online: 30 October 2020
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of Policlinico Umberto I Hospital, Sapienza University of Rome, Italy. All patients were asked to sign an informed consent form authorizing inclusion of their clinical data in the study database.
: NJS has consulted for Vertex Pharmaceuticals, Gilead, Teva, Roche, Chiesi, Pulmocide and PTC Therapeutics. The other authors declare that they have no financial and personal relationships with other people or organizations that could inappropriately influence their work.